98%
921
2 minutes
20
It is generally accepted that as bovine respiratory disease (BRD) develops, bacterial pathogens first proliferate in the nasopharynx and then colonize the lungs, leading to bronchopneumonia. However, such temporal changes have never been definitively demonstrated. Therefore, the objective was to describe the progression of the nasopharyngeal and tracheal bacterial microbiotas of feedlot cattle during development of BRD. Nasopharyngeal swabs and tracheal wash samples were collected from 24 heifers over 20 d after arrival at a feedlot. Heifers were assessed daily and sampled based on reticulo-rumen/rectal temperatures and development of clinical signs of BRD. The study end point for each heifer was either at BRD treatment (BRD group; n = 15) or day 20 if the heifer remained healthy or did not meet BRD treatment criteria (TOL group; n = 9). Total DNA was extracted from each sample and the 16S rRNA gene (V3-V4) sequenced. Alpha and beta diversity were compared between BRD-TOL groups and sampling locations over time. There were no common patterns of change over time in composition or diversity of either the nasopharyngeal or tracheal bacterial microbiotas of cattle that developed BRD. Health status affected bacterial composition (R = 0.043; < 0.001), though this effect was low compared to variation among individual animals (R = 0.335; < 0.001) and effects of days on feed (R = 0.082; < 0.001). Specific bacterial taxa (Moraxella and Mycoplasma dispar) nevertheless appeared to have a potential role in respiratory health.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.vetmic.2020.108826 | DOI Listing |
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
September 2025
To summarize the clinical characteristics, diagnosis and treatment experience of salivary pleomorphic adenoma in children. Thirty patients with salivary pleomorphic adenomas treated in Beijing Childrens Hospital from January 2008 to December 2022 were retrospectively reviewed, including 11 boys and 19 girls, with the age ranging from 0.3 to 14.
View Article and Find Full Text PDFAm J Trop Med Hyg
August 2025
Department of Paediatrics, Christian Medical College and Hospital, Vellore, India.
Identification of the etiological agent in severe pneumonia is limited by factors such as the poor yield from blood samples and the presence of colonizers in the respiratory tract. Samples from the lower respiratory tract could be more representative of the etiological agent causing pneumonia. We conducted a case-control study to determine the etiology of community-acquired severe pneumonia requiring intubation.
View Article and Find Full Text PDFCochrane Database Syst Rev
June 2025
Department of Applied Health Sciences, University of Birmingham, Birmingham, UK.
Background: Accurate and prompt diagnosis of tuberculosis in children is challenging due to non-specific clinical presentation and the low bacillary load of samples. Low-complexity manual nucleic acid amplification tests (LC-mNAATs) such as loop-mediated isothermal amplification (TB-LAMP) are World Health Organization (WHO)-recommended rapid molecular diagnostic tests. Even in resource-limited settings, they have good diagnostic accuracy in adults.
View Article and Find Full Text PDFMethodsX
June 2025
Laboratorio de Biomedicina Experimental, Facultad de Medicina, Campus Saucache, Universidad de Tarapacá, Avenida Senador Luis Valente Rossi, Arica, Chile.
Shannon entropy data were obtained from whole genome sequences of SARS-CoV-2 virus from COVID-19 positive patients from nasopharyngeal and tracheal aspirate samples, these sequences were downloaded from the NCBI public database. The study included 57 genomic sequences of the SARS-CoV-2 virus. A total of 57 samples ( = 30 oronasopharyngeal and = 27 tracheal aspirates) underwent bioinformatics-based analysis with the objective of determining the extent of viral variability.
View Article and Find Full Text PDFInfluenza Other Respir Viruses
May 2025
Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong SAR, China.
Background And Objectives: This randomised controlled trial evaluated whether higher doses of oseltamivir would improve virological and clinical outcomes in severe influenza patients requiring invasive mechanical ventilation.
Methods: Forty intubated adult patients with severe influenza A or B from four intensive care units in Hong Kong were enrolled and randomised to receive either a double dose (300 mg/day) or a triple dose (450 mg/day) of oseltamivir for 10 days. Baseline data were collected, and outcomes were assessed daily using SOFA and Murray scores.